Showing results (31-40 of 182) with videos related to
Sort By:
Pageof 19
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Hikikomori: A Society-Bound Syndrome of Severe Social WithdrawalBin Dong, Daniel Li, Glen B BakerContraception|January 17, 2015
Benchmark pregnancy rates and the assessment of post-coital contraceptives: an updateDaniel Li, Allen J Wilcox, David B DunsonContemporary Clinical Trials Communications|December 5, 2019
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacyRevathi Ananthakrishnan, Stephanie Green, Daniel Li, et al.General Hospital Psychiatry|January 12, 2021
COVID-19 pandemic inpatient bed allocation planning - A Canada-wide approachAntonio Paletta, Dorothy Yu, Daniel Li, et al.Contemporary Clinical Trials Communications|April 27, 2018
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trialsRevathi Ananthakrishnan, Stephanie Green, Daniel Li, et al.Heart Failure Reviews|February 3, 2022
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyondSalil Kumar, Daniel Li, Denny Joseph, et al.Current Diabetes Reports|July 26, 2015
Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisDaniel Li, Jennifer Kirsop, W H Wilson TangPharmaceutical Statistics|March 5, 2023
Bayesian optimal phase II designs with dual-criterion decision makingYujie Zhao, Daniel Li, Rong Liu, et al.Epidemiology (Cambridge, Mass.)|September 21, 2013
Lipid adjustment for chemical exposures: accounting for concomitant variablesDaniel Li, Matthew P Longnecker, David B DunsonChemmedchem|July 13, 2023
H2 O2 -Inducible DNA Cross-linking Agents Capable of Releasing Multiple DNA Alkylators as Anticancer ProdrugsSheng Cao, Yibin Wang, Daniel Li, et al.Pageof 19